0.05Open0.05Pre Close0 Volume1 Open Interest10.00Strike Price0.00Turnover403.35%IV498.21%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier21DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0922Delta0.1004Gamma33.60Leverage Ratio-0.0062Theta0.0001Rho3.10Eff Leverage0.0007Vega
PepGen Stock Discussion
“Phase 1 data to be shared at the Muscular Dystrophy Association (MDA) on March 19, 2025. Phase 1 initial data showed that the 10 mg/kg dose of PGN-EDODM1 achieved a significant mean splicing correction of 29.1% with a favorable emerging safety profile, noted February 24, 2025. Phase 1 FREEDOM 15 mg/kg cohort to report data in 2H 2025 and from the FREEDOM2 5 mg/kg cohort 1Q 2026.”
“Phase 2 12-Week data to b...
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
Tuesday, 4th March at 8:00 am
Company will temporarily pause CONNECT2 and focus efforts on ongoing CONNECT1-EDO51 study of PGN-EDO51 in DMD, with 10 mg/kg results expected in the third quarter of 2025
No new safety issues have been observed in PGN-EDO51 program
PepGen Inc. (NASDAQ: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal...
$DIH Holding US (DHAI.US)$ 0.355-0.530 = 49.30%
$Expensify (EXFY.US)$ 3.4-3.979 = 17.02%
$Organogenesis (ORGO.US)$ 3.232-6.75 = 108%
$PepGen (PEPG.US)$ 2.216-3.34 = 50.72%
$Powell Max (PMAX.US)$ 0.590-0.726 = 23%
$Rapid Micro Biosystems (RPID.US)$ 3.934-4.87 = 23.67%
$SoundHound AI (SOUN.US)$ 8.96-10.94 = 22.10%
$Newton Golf (SPGC.US)$ 0.174-0.265 = 52.30%
$Tiziana Life Sciences (TLSA.US)$ 1.13-1.3...
another breakout today 🙏🙏
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, I...
No comment yet